Affiliation:
1. MD( Pharmacology), Assistant Professor Of Pharmacology, Government Vellore Medical College, Vellore-11.
2. MD( Pharmacology), Associate Professor Of Pharmacology, Government Vellore Medical College, Vellore-11.
Abstract
BACKGROUND
Bronchial Asthma is one of the worldwide health problem associated with increased morbidity and mortality. Bronchial Asthma is a disease of airways that is characterized by hyper-responsiveness of the trachea-bronchial tree to various stimuli. Corticosteroids afford more complete and sustained symptomatic relief than other bronchodilators, but it has its own adverse effects worser than asthma itself. Assessment of adverse effects of oral corticosteroids in asthmatic patients, will play a vital role in alerting physicians regarding the possibility of such events, thereby helping them to protect the user population from such harm.
METHODOLOGY
The study was conducted at asthma OPD, Rajiv Gandhi Government General Hospital, Chennai, with 300 asthmatic patients on Oral corticosteroids, fulfilling the study criteria and were observed for three months. Their prescriptions &ADR forms were collected and analysed. The causality assessment was done by WHO-UMC assessment scale and severity by using Modified Hartwig-Seigel severity assessment scale.
RESULTS
Prednisolone was the most commonly prescribed oral corticosteroid drug. 18% of patients encountered Adverse Drug Reactions. Epigastric pain (33%) was the most common Adverse Drug Reaction encountered and was more common in elderly females (61-70 years). Most of the ADRs were mild and comes under possible category of WHO causality assessment scale.
CONCLUSION
Our study offers a representative idea of the ADR profile of oral corticosteroids. Oral corticosteroids though taken for limited period, is found to cause adverse effects. Hence it would be better to switch over to inhaled corticosteroids. If unavoidable, they can be used as a rescue therapy for short term (5-7 days)
Reference14 articles.
1. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Loscalzo J and Jameson JL, eds. Harrison’s Principles of Internal Medicine: 18th Ed. McGraw-Hill, New York; 2012:254.
2. Masoli M, Fabian D, Holt S, Beasley R. Global burden of asthma. Developed for the Global Initiative for Asthma (GINA). Allergy. 2004;59:469-78.
3. World health reports 2001. Fifty facts from the world health report 1998: Global Health Situation and Trends: WHO: 2001;1955-2025.
4. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997 May 17;349(9063):1436- 42.
5. National commission on Macroeconomics and health- Burden of disease in India. Available at: https://www.who.int/macrohealth/action/Report%20o f%20the%20National%20Commission.pdf?ua=1. 2005; 251:63.